Product Description
Griseofulvin is used to treat skin infections such as jock itch, athlete's foot, and ringworm; and fungal infections of the scalp, fingernails, and toenails. (Sourced from: https://medlineplus.gov/druginfo/meds/a682295.html)
Mechanisms of Action: Tubulin Inhibitor,Mitosis Inhibitor,Fungal Growth Inhibitor
Novel Mechanism: No
Modality: Small Molecule
Route of Administration: Oral
FDA Designation: *
Approval Status: Approved
Approved Countries: Australia | Bangladesh | Brazil | Canada | Chile | China | Colombia | Cyprus | Dominican Republic | Ecuador | Egypt | France | Germany | Hong Kong | India | Indonesia | Ireland | Italy | Jordan | Korea | Lebanon | Malaysia | Malta | Morocco | New Zealand | Pakistan | Peru | Portugal | Russia | Saudi Arabia | Singapore | Slovenia | South Africa | Sri Lanka | Taiwan | Thailand | Turkey | Ukraine | United Kingdom | United States | Venezuela | Vietnam
Approved Indications: None
Known Adverse Events: None
Company: None
Company Location:
Company CEO:
Additional Commercial Interests: None
Clinical Description
Countries in Clinic:
Active Clinical Trial Count:
Recent & Upcoming Milestones
Highest Development Phases
Trial |
Phase |
Trial Status |
Disease |
Primary Completion Date |
Probability of Success |
Latest Trial Update Date |
Data Updated |
|---|
Recent News Events
Date |
Type |
Title |
|---|---|---|
|
03/02/2023 |
News Article |
Possible Dangers and SPF Misconceptions of Sunscreens for Sunbathing Investigated by Scientist, Dr. Win L. Chiou |
|
12/06/2022 |
News Article |
Cosette Pharmaceuticals Announces the launch of Griseofulvin Oral Suspension, 125 mg/5 mL. |
|
04/11/2022 |
News Article |
Onychomycosis Treatment Market Opportunities, Size, Share, Emerging Trends, Technological Innovation and Forecast 2022-2031 |
|
02/07/2022 |
News Article |
Onychomycosis Treatment Market By Key Players, Deployment Type, Applications, Vertical, and Region – Forecast |